Business Context and Reporting Period
This Form 8-K Current Report was filed by Achieve Life Sciences, Inc. on September 11, 2025, covering the event date of September 5, 2025. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol ACHV.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Executive Departure: Dr. Cindy Jacobs has resigned from her roles as Chief Medical Officer and President.
- Effective Date: The resignation is effective as of October 6, 2025.
- Future Engagement: The Company is negotiating a consulting agreement for Dr. Jacobs to provide advisory services post-resignation.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or specific risk factors beyond the operational impact of the executive departure. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Confirm the final terms of the consulting agreement with Dr. Jacobs, including compensation and scope of services.
- Monitor for announcements regarding the interim or permanent replacement for the Chief Medical Officer and President roles.
- Review subsequent filings for any impact on the company's clinical development pipeline or strategic direction.